|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| C07K 16/00 | |||
| C07K 16/46 | |||
| A61K 39/385 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| C12N 5/20 | |||
| G01N 33/577 | |||
| C12N 15/13 | |||
| A61K 47/48 | |||
| G01N 33/68 |
| (11) | Number of the document | 2272869 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10011651.6 |
| Date of filing the European patent application | 2002-10-11 | |
| (97) | Date of publication of the European application | 2011-01-12 |
| (45) | Date of publication and mention of the grant of the patent | 2013-11-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 328604 P | 2001-10-11 | US | |
| 269805 | 2002-10-10 | US |
| (72) |
Oliner, Jonathan Daniel, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | Angiopoietin-2 specific binding agents |
| Angiopoietin-2 specific binding agents |